Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Zimmer Biomet Holdings Stock (ISIN: US98956P1021) Faces Institutional Selling Pressure Amid Steady D
Zimmer Biomet Holdings (NYSE: ZBH) is experiencing institutional selling pressure, with funds like SIIT S&P 500 Index Fund and Moore Capital trimming their positions. Despite these divestments, the company has reaffirmed its quarterly dividend, signaling stability in the medtech sector. Analysts maintain a “Moderate Buy” sentiment with an 8.54% upside potential, highlighting the stock’s resilience and appeal to risk-averse European investors seeking stable US healthcare exposure.